James P. Brady

Human Resources Officer en SPERO THERAPEUTICS, INC. .

Health Technology

Consumer Services

Perfil

James P.
Brady is currently the Chief Human Resource Officer at Spero Therapeutics, Inc. Previously, he held the position of Vice President-Human Resources at Intarcia Therapeutics, Inc. and was the Chief Human Resources Officer at uniQure NV.
He received a graduate degree from Harvard University and an undergraduate degree from Marietta College.

Cargos activos de James P. Brady

Empresas	Cargo	Inicio
SPERO THERAPEUTICS, INC.	Human Resources Officer	-

Todos los cargos activos de James P. Brady

Antiguos cargos conocidos de James P. Brady.

Empresas	Cargo	Fin
UNIQURE N.V.	Human Resources Officer	-
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.	Human Resources Officer	-

Ver el detalle de la experiencia de James P. Brady.

Formación de James P. Brady.

Harvard University	Graduate Degree
Marietta College	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de James P. Brady.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
UNIQURE N.V.	Health Technology
SPERO THERAPEUTICS, INC.	Health Technology

Empresas privadas	1
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.	Health Technology